paclitaxel has been researched along with Abnormalities, Autosome in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 15 (68.18) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Churin, AA; Fedorova, EP; Filonova, MV; Neupokoeva, OV; Sandrikina, LA; Stavrova, LA; Voronova, OL | 1 |
| Afonso, CMM; Azevedo, CMG; Bousbaa, H; França, F; Henriques, AC; Loureiro, DRP; Silva, PMA; Soares, JX | 1 |
| Cooper, PA; Cross, SJ; O'Flaherty, L; Pardo, OE; Seckl, MJ; Shnyder, SD; Tavaré, JM; Wakefield, JG | 1 |
| Haruta, M; Higuchi, T; Inoue, K; Kaneko, Y; Kasai, F; Kurosumi, M; Miyazaki, M; Ogawa, S; Sato-Otsubo, A; Takada, M; Takei, H; Tozuka, K; Watanabe, J | 1 |
| Al-Azzam, S; Alzoubi, K; Khabour, O; Khader, M; Mhaidat, N | 1 |
| Irie, T; Mori, A; Morioka, M; Saito, M; Tanaka, M | 1 |
| Bastians, H; Ertych, N; Kienitz, A; Schneider, V; Stolz, A; Vogel, C; Yu, H | 1 |
| Aruga, C; Aubrecht, J; Bauer, D; Boitier, E; Deng, S; Dickinson, D; Ellinger-Ziegelbauer, H; Fornace, AJ; Fostel, JM; Grenet, O; Gu, Y; Hoflack, JC; Le Fevre, AC; Shiiyama, M; Smith, R; Snyder, RD; Spire, C; Tanaka, G | 1 |
| Bhat, A; Feng, Z; Gupta, A; Hunt, CR; Jeffery, J; Kaul, SC; Khanna, KK; Kumar, R; Misri, S; Pagan, J; Pandita, RK; Pandita, TK; Parsons, R; Powell, SN; Puc, J; Wadhwa, R; Xiang, T; Yaguchi, T; Yang, Q; Zeng, S | 1 |
| Tanaka, J; Tanaka, T; Toujima, S | 1 |
| Balis, F; Bates, S; Cole, D; Egorin, MJ; Flynn, BM; Fojo, T; Knutsen, T; Langham, G; Rao, VK; Ried, T; Steinberg, SM; Wangsa, D | 1 |
| Muehlbauer, PA; Schuler, MJ | 1 |
| Degrassi, F; Fiore, M; Mattiuzzo, M; Ricordy, R | 1 |
| Cieslak, J; Ilkevitch, Y; Kuznyetsov, V; Shkumatov, A; Verlinsky, Y | 1 |
| Alvarez Marcos, CA; de Bock, GH; Gibcus, JH; Hermsen, MA; Kluin, PM; Kok, K; Langendijk, JA; Mastik, MF; Menkema, L; Schuuring, E; Takes, RP; van den Brekel, MW; van der Laan, BF; van der Wal, JE; van Velthuysen, ML | 1 |
| Adiga, SK; Jagetia, GC | 1 |
| Chakrabarti, A; Hueser, CN; Schatten, H | 1 |
| Cha, KY; Chung, HM; Hwang, WS; Lee, ES; Lim, JM; Park, SE | 1 |
| Ahmed, MM; Akpinar, G; Aydemir, N; Ceçener, G; Cimen, C; Egeli, U; Engin, K; Ergül, E; Kahraman-Cetintaş, S; Ozkan, L; Ozuysal, S; Tunca, B | 1 |
| Dawe, RK; Hiatt, EN; Kentner, EK | 1 |
| Boletis, J; Chiras, T; Kosmas, C; Kostakis, A; Tsavaris, NB; Vadiaka, M | 1 |
| Goto, T; Kikuchi, Y; Kita, T; Kudo, K; Takano, M; Yamamoto, K | 1 |
1 review(s) available for paclitaxel and Abnormalities, Autosome
| Article | Year |
|---|---|
Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer.
Topics: Chromosome Aberrations; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Nucleic Acid Hybridization; Ovarian Neoplasms; Paclitaxel; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 2001 |
21 other study(ies) available for paclitaxel and Abnormalities, Autosome
| Article | Year |
|---|---|
Dalayed Effects of Antitumor Drug Paclitaxel on the Hereditary Material and Hemopoietic System of CBA Mice.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Chromosome Aberrations; Cytogenetic Analysis; Erythropoiesis; Female; Genome; Genomic Instability; Hematopoiesis; Male; Mice; Mice, Inbred CBA; Mutagenicity Tests; Paclitaxel | 2020 |
A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel.
Topics: Antimitotic Agents; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Chemistry Techniques, Synthetic; Chromosome Aberrations; Fluorescent Antibody Technique; Humans; M Phase Cell Cycle Checkpoints; Microtubules; Mitosis; Molecular Structure; Paclitaxel; Pyrans; Xanthones | 2020 |
Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chromosome Aberrations; Drug Synergism; Drug Therapy, Combination; Glycogen Synthase Kinase 3; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Paclitaxel; Pyridines; Pyrimidines; RNA Interference; RNA, Small Interfering | 2019 |
Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemot
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chromosome Aberrations; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Dosage; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Neoadjuvant Therapy; Oligonucleotide Array Sequence Analysis; Paclitaxel; Phosphatidylinositol 3-Kinases; Polymorphism, Single Nucleotide; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; Survival Rate; Trastuzumab | 2013 |
Evaluation of vitamin B12 effects on DNA damage induced by paclitaxel.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Antineoplastic Agents, Phytogenic; Antioxidants; Cells, Cultured; Chromosome Aberrations; Deoxyguanosine; DNA Damage; Humans; Lymphocytes; Male; Paclitaxel; Sister Chromatid Exchange; Vitamin B 12; Young Adult | 2014 |
[Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
Topics: Antineoplastic Agents, Phytogenic; Bone Marrow Neoplasms; Breast Neoplasms; Chromosome Aberrations; Chromosomes, Human, Pair 11; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Paclitaxel | 2009 |
Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells.
Topics: Apoptosis; Aurora Kinase B; Aurora Kinases; Carbazoles; Chromosome Aberrations; Colonic Neoplasms; Drug Synergism; Enzyme Inhibitors; HCT116 Cells; Humans; Mitosis; Nocodazole; Paclitaxel; Protein Serine-Threonine Kinases; Spindle Apparatus | 2009 |
Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromosome Aberrations; Cisplatin; Cluster Analysis; DNA Adducts; DNA Breaks, Double-Stranded; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Gene Expression Profiling; Gene Expression Regulation; Humans; Laboratories; Mutagenicity Tests; Mutagens; Observer Variation; Paclitaxel; Polymerase Chain Reaction; Reproducibility of Results; Risk Assessment; Sodium Chloride; Spindle Apparatus; Time Factors | 2009 |
Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair.
Topics: Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia Mutated Proteins; Caffeine; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Chromosome Aberrations; DNA Breaks, Double-Stranded; DNA Repair; DNA-Binding Proteins; Genomic Instability; Humans; Infrared Rays; Karyotyping; Paclitaxel; Phosphorylation; Protein Serine-Threonine Kinases; PTEN Phosphohydrolase; Rad51 Recombinase; RNA, Small Interfering; Telomere; Tumor Suppressor Proteins | 2009 |
Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Antigens, Surface; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Chromosome Aberrations; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Karyotype; Paclitaxel | 2012 |
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration.
Topics: Animals; Area Under Curve; Azure Stains; Bone Marrow Cells; Chromosome Aberrations; Chromosome Painting; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Etoposide; Infusions, Intravenous; Macaca mulatta; Neutropenia; Paclitaxel; Thiotepa | 2005 |
Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents.
Topics: Adult; Aneugens; Cells, Cultured; Chromosome Aberrations; Etoposide; Female; Flow Cytometry; Griseofulvin; Humans; Lymphocytes; Male; Mitomycin; Mitosis; Mutagenicity Tests; Paclitaxel; Polyploidy | 2005 |
Aneuploidy-inducing capacity of two widely used pesticides.
Topics: Acetamides; Aneuploidy; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line; Chromosome Aberrations; Chromosomes, Human; Dichlorvos; Herbicides; Humans; Insecticides; Paclitaxel | 2006 |
Obtaining metaphase spreads from single blastomeres for PGD of chromosomal rearrangements.
Topics: Animals; Blastomeres; Caffeine; Chromosome Aberrations; Culture Media; Cytoplasm; Demecolcine; Embryo Culture Techniques; Humans; Marine Toxins; Metaphase; Mice; Oxazoles; Paclitaxel; Preimplantation Diagnosis; Zygote | 2007 |
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Cycle; Chromosome Aberrations; Chromosome Mapping; Chromosomes, Human, Pair 11; Fas-Associated Death Domain Protein; Gene Expression Profiling; Humans; Laryngeal Neoplasms; Nucleic Acid Hybridization; Paclitaxel; Pharyngeal Neoplasms; Phosphorylation; Time Factors | 2007 |
Correlation between micronuclei induction and cell survival in V79 cells exposed to paclitaxel (taxol) in conjunction with radiation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Division; Cell Line; Cell Survival; Chromosome Aberrations; Cricetinae; Cricetulus; Dose-Response Relationship, Radiation; Gamma Rays; Micronuclei, Chromosome-Defective; Paclitaxel; Radiation-Sensitizing Agents | 1997 |
From fertilization to cancer: the role of centrosomes in the union and separation of genomic material.
Topics: Animals; Calcimycin; Cell Division; Centrosome; Chromosome Aberrations; Dithiothreitol; DNA; Fertilization; Formamides; Hydrogen-Ion Concentration; Male; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Microtubules; Ovum; Paclitaxel; Quaternary Ammonium Compounds; Sea Urchins; Spermatozoa | 2000 |
Cryopreservation of ICR mouse oocytes: improved post-thawed preimplantation development after vitrification using Taxol, a cytoskeleton stabilizer.
Topics: Animals; Chromosome Aberrations; Chromosome Disorders; Cryopreservation; Culture Techniques; Cytoskeleton; Embryo, Mammalian; Embryonic and Fetal Development; Embryonic Development; Feasibility Studies; Female; Fertilization in Vitro; Mice; Mice, Inbred ICR; Oocytes; Paclitaxel; Pregnancy; Spindle Apparatus | 2001 |
Investigation of genotoxic effect of taxol plus radiation on mice bone marrow cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Marrow Cells; Cell Cycle; Chromosome Aberrations; Combined Modality Therapy; Dose-Response Relationship, Radiation; Mice; Mitosis; Mitotic Index; Paclitaxel; Radiation-Sensitizing Agents | 2002 |
Independently regulated neocentromere activity of two classes of tandem repeat arrays.
Topics: Carrier Proteins; Centromere; Chromosome Aberrations; Gene Expression Regulation, Plant; In Situ Hybridization; Meiosis; Microtubules; Paclitaxel; Plant Structures; Tandem Repeat Sequences; Zea mays | 2002 |
Extragonadal seminoma after renal transplantation and immunosuppression; treatment in the presence of renal dysfunction: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chromosome Aberrations; Chromosomes, Human, Pair 12; Diagnosis, Differential; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Paclitaxel; Pelvic Neoplasms; Seminoma | 2001 |